EDITAS MEDICINE, INC. (EDIT) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $4.74M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value $36.31M; Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $4.74M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $4.74M |
| Deferred revenue · latest quarter (USD) | $36.31M | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. $32.31M + $4.00M ≈ $36.31M |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | $2.41M | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. $2.41M − $0.00 ≈ $2.41M |
Calculation inputs
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- $2.41M
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $15.51M |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $4.74M | $36.31M | (m) | $2.41M | $132.08M | (m) | $32.31M | $4.00M | $2.41M | $0.00 |
| 2026-03-31 | (m) | $4.33M | $44.51M | (m) | $2.87M | $144.93M | (m) | (m) | $44.51M | $2.87M | $0.00 |
| 2025-12-31 | (m) | $2.60M | $44.51M | (m) | $2.81M | $159.25M | (m) | $0.00 | $44.51M | $2.81M | $0.00 |
| 2025-09-30 | (m) | $3.16M | $54.20M | (m) | $4.69M | $188.30M | (m) | $0.00 | $54.20M | $4.69M | $0.00 |
| 2025-06-30 | (m) | $6.72M | $54.20M | (m) | $4.59M | $191.39M | (m) | $0.00 | $54.20M | $4.59M | $0.00 |
| 2025-03-31 | (m) | $5.46M | $56.20M | (m) | $6.36M | $201.23M | (m) | $2.00M | $54.20M | $6.36M | $0.00 |
| 2024-12-31 | (m) | $5.49M | $60.42M | (m) | $3.07M | $207.31M | (m) | $6.22M | $54.20M | $3.07M | $0.00 |
| 2024-09-30 | (m) | $12.49M | $68.89M | (m) | $3.28M | $151.93M | (m) | $14.68M | $54.20M | $3.28M | $0.00 |
| 2024-06-30 | (m) | $13.77M | $68.89M | (m) | $3.77M | $152.79M | (m) | $14.68M | $54.20M | $3.77M | $0.00 |
| 2024-03-31 | (m) | $7.97M | $68.89M | (m) | $3.47M | $145.95M | (m) | $14.68M | $54.20M | $3.47M | $0.00 |
| 2023-12-31 | (m) | $8.27M | $68.89M | (m) | $1.80M | $150.06M | (m) | $8.22M | $60.67M | $1.80M | $0.00 |
| 2023-09-30 | (m) | $10.41M | $68.89M | (m) | (m) | $144.19M | (m) | $8.22M | $60.67M | (m) | $0.00 |
| 2023-06-30 | (m) | $8.07M | $68.89M | (m) | (m) | $142.04M | (m) | $8.22M | $60.67M | (m) | $0.00 |
| 2023-03-31 | (m) | $9.05M | $68.89M | (m) | (m) | $146.63M | (m) | $8.22M | $60.67M | (m) | $0.00 |
| 2022-12-31 | (m) | $9.51M | $68.89M | (m) | (m) | $153.64M | (m) | $8.22M | $60.67M | (m) | $0.00 |
| 2022-09-30 | (m) | $6.84M | $68.89M | (m) | (m) | $116.28M | (m) | $4.22M | $64.67M | (m) | $0.00 |
| 2022-06-30 | (m) | $6.17M | $68.89M | (m) | (m) | $115.42M | (m) | (m) | $68.89M | (m) | $0.00 |
| 2022-03-31 | (m) | $4.69M | $66.70M | (m) | (m) | $110.35M | (m) | $5.82M | $60.89M | (m) | $0.00 |
| 2021-12-31 | (m) | $5.05M | $72.22M | (m) | (m) | $123.84M | (m) | $11.33M | $60.89M | (m) | $0.00 |
| 2021-09-30 | (m) | $3.40M | $83.56M | (m) | (m) | $130.22M | (m) | $22.67M | $60.89M | (m) | $0.00 |
| 2021-06-30 | (m) | $4.42M | $89.22M | (m) | (m) | $142.52M | (m) | $34.00M | $55.22M | (m) | $0.00 |
| 2021-03-31 | (m) | $8.91M | $89.37M | (m) | (m) | $142.30M | (m) | $32.70M | $56.67M | (m) | $0.00 |
| 2020-12-31 | (m) | $6.41M | $94.93M | (m) | $27.50M | $179.02M | (m) | $20.94M | $73.98M | $27.50M | $0.00 |
| 2020-09-30 | (m) | $5.16M | $100.69M | $3.13M | (m) | $156.00M | (m) | $19.87M | $80.82M | (m) | $0.00 |
| 2020-06-30 | (m) | $6.34M | $179.35M | $4.03M | (m) | $228.71M | (m) | $40.94M | $138.41M | (m) | $0.00 |
| 2020-03-31 | (m) | $10.39M | $182.41M | $3.52M | $1.00K | $232.17M | (m) | $40.64M | $141.77M | $1.00K | $0.00 |
| 2019-12-31 | (m) | $5.84M | $186.72M | $2.68M | $1.00K | $246.45M | (m) | $23.51M | $163.21M | $1.00K | $0.00 |
| 2019-09-30 | (m) | $6.62M | $128.40M | $1.56M | $1.00K | $162.37M | (m) | $46.02M | $82.38M | $1.00K | $0.00 |
| 2019-06-30 | (m) | $3.98M | $131.95M | $1.03M | $1.00K | $162.56M | (m) | $56.04M | $75.91M | $1.00K | $0.00 |
| 2019-03-31 | (m) | $6.56M | $129.26M | $1.91M | $1.00K | $161.75M | (m) | $23.40M | $105.86M | $1.00K | $0.00 |
| 2018-12-31 | (m) | $5.33M | $131.33M | $2.05M | $293.00K | $184.22M | (m) | $15.71M | $115.61M | $293.00K | $0.00 |
| 2018-09-30 | (m) | $5.04M | $112.83M | $980.00K | $301.00K | $163.18M | (m) | $8.72M | $104.10M | $301.00K | $0.00 |
| 2018-06-30 | (m) | $4.66M | $112.31M | $944.00K | $305.00K | $162.20M | (m) | $7.39M | $104.93M | $305.00K | $0.00 |
| 2018-03-31 | (m) | $9.00M | $105.30M | $908.00K | $311.00K | $156.47M | (m) | $13.32M | $91.97M | $311.00K | $0.00 |
| 2018-01-01 | (m) | (m) | $108.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $4.02M | $107.96M | $900.00K | $317.00K | $165.18M | (m) | $13.24M | $94.72M | $317.00K | $0.00 |
| 2017-09-30 | (m) | $6.98M | $111.09M | $831.00K | $325.00K | $161.34M | (m) | $13.24M | $97.85M | $325.00K | $0.00 |
| 2017-06-30 | (m) | $8.16M | $114.19M | $1.13M | $328.00K | $183.84M | (m) | $13.24M | $100.95M | $328.00K | $0.00 |
| 2017-03-31 | (m) | $15.23M | (m) | $13.29M | $331.00K | $188.58M | (m) | (m) | $104.03M | $331.00K | $0.00 |
| 2016-12-31 | (m) | $4.64M | (m) | $986.00K | $16.00K | $94.58M | (m) | (m) | $26.00M | $16.00K | $0.00 |
| 2016-09-30 | (m) | $3.72M | (m) | $547.00K | $19.00K | $71.98M | (m) | (m) | $25.80M | $19.00K | $0.00 |
| 2016-06-30 | (m) | $5.84M | (m) | (m) | $21.00K | $62.27M | (m) | (m) | $25.64M | $21.00K | $0.00 |
| 2016-03-31 | (m) | $2.91M | (m) | (m) | $24.00K | $47.45M | (m) | (m) | $25.48M | $24.00K | $0.00 |
| 2015-12-31 | (m) | $1.38M | (m) | (m) | $27.00K | $32.56M | (m) | (m) | $25.32M | $27.00K | $0.00 |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |